Jazz Pharmaceuticals plc annual free cash flow for fiscal 2025 was $1.1 billion, a decrease of 15.0% from $1.3 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $1.1B | $1.3B | $1.0B | $774M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Free Cash Flow | $388M | $292M | $387M | $76M | $391M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More JAZZ metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS
All JAZZ financial statements → Interactive JAZZ charts →
About TickerBase · Data methodology & sources